Annals On Call - Gabapentinoids and COPD: Not a Good Mix?
Authors: Robert M. Centor, Alvi A. Rahman, Christel Renoux
Journal: Annals of Internal Medicine (2024)

Web Exclusives5 March 2024Annals On Call - Gabapentinoids and COPD: Not a Good Mix?FREERobert M. Centor, MD, Alvi A. Rahman, MSc, and Christel Renoux, MD, PhDRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.), Alvi A. Rahman, MScDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, and Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada (A.A.R.), and Christel Renoux, MD, PhDDepartment of Epidemiology, Biostatistics and Occupational Health, Department of Medicine, and Department of Neurology and Neurosurgery, McGill University, and Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada (C.R.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/A23-0005 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses the association between gabapentinoids and chronic obstructive pulmonary disease with Mr. Rahman and Dr. Renoux.Annals articles discussed include...Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease. A Population-Based Cohort Study: https://www.acpjournals.org/doi/10.7326/M23-0849About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Robert M. Centor, MD; Alvi A. Rahman, MSc; Christel Renoux, MD, PhDAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Department of Epidemiology, Biostatistics and Occupational Health, McGill University, and Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada (A.A.R.)Department of Epidemiology, Biostatistics and Occupational Health, Department of Medicine, and Department of Neurology and Neurosurgery, McGill University, and Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada (C.R.)Disclosures: All relevant financial relationships have been mitigated. Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=A23-0005.Editors' Disclosures: The editors have no relevant financial relationships to disclose. Individual forms may be viewed at www.annals.org/editorsdisclosures.This article was published at Annals.org on 5 March 2024. Nextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoGabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease Alvi A. Rahman , Sophie Dell'Aniello , Erica E.M. Moodie , Madeleine Durand , Janie Coulombe , Jean-François Boivin , Samy Suissa , Pierre Ernst , and Christel Renoux Metrics Latest ePublished: 5 March 2024 Copyright & PermissionsCopyright © 2024 by American College of Physicians. All Rights Reserved.Loading ...